The use of MDS to access the presence of melanoma in the skin.
A topical agent is applied to suspicious skin lesions and imaged. The images are analyzed to provide a score that correlates with the probability for the presence of melanoma in the lesion.
Study Type
OBSERVATIONAL
Enrollment
357
Clalit Health Services
Kiryat Bialik, Israel
Ziv Medical Center
Safed, Israel
To validate the performance of MDS
Time frame: 28 days
To calculate and specify the PPV and NPV of the MDS for melanoma detection when used as an adjacent tool to visual skin examination.
Time frame: 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.